aspartic acid has been researched along with Infections, Pseudomonas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachta, KER; Bertucci, HK; Brunzelle, JS; Gatesy, SWM; Hauser, AR; Lebrun-Corbin, M; Minasov, G; Ozer, EA; Pincus, NB; Rosas-Lemus, M; Satchell, KJF; Shuvalova, LA | 1 |
| Akinbi, HT; Ballard, TN; Nash, JA; Weaver, TE | 1 |
2 other study(ies) available for aspartic acid and Infections, Pseudomonas
| Article | Year |
|---|---|
Functional and Structural Characterization of OXA-935, a Novel OXA-10-Family β-Lactamase from Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aspartic Acid; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporinase; Cephalosporins; Glycine; Humans; Microbial Sensitivity Tests; Phenylalanine; Pseudomonas aeruginosa; Pseudomonas Infections; Serine; Tazobactam | 2022 |
The peptidoglycan-degrading property of lysozyme is not required for bactericidal activity in vivo.
Topics: Animals; Aspartic Acid; Blood Bactericidal Activity; Bronchoalveolar Lavage Fluid; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Knockout; Mice, Transgenic; Muramidase; Mutagenesis, Site-Directed; Peptidoglycan; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Respiratory Mucosa; Serine; Staphylococcal Infections; Staphylococcus aureus | 2006 |